Water therapy, knee braces, and exercise are more effective than high-tech treatments like ultrasound therapy for knee ...

Resistance and nonresponse to aspirin dramatically decreases its therapeutic efficacy. To overcome this issue, a small-molecule thrombus-targeting drug delivery system, aspirin-Arg-Gly-Asp-Val (A-RGDV ...

Aspire Biopharma Holdings, Inc., Announces First Patient Dosed in Phase 1 Clinical Trial for its Lead Program, an Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation ...

Aspirin has been the subject of extensive medical research, with scientists continually investigating its multifaceted therapeutic potential and associated risks (Werz et al., 2024). Initially studied ...

HUMACAO, PR AND NEW YORK, NY / ACCESS Newswire / April 9, 2025 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), a developer of a multi-faceted patent-pending drug delivery ...

Scientists have described the “Eureka moment” when they discovered how aspirin may prevent some cancers from spreading. Their new research builds on existing evidence and suggests aspirin ...

BSO: Buthionine sulfoximine; DMARD: Disease-modifying antirheumatic drug; H 2 S: Hydrogen sulfide; GSH: Glutathione; LUTS: Lower urinary tract syndromes; PDE5: Type 5 phosphodiesterase. Hydrogen ...

Further, aspirin produced a 59.2% reduction in liver fat compared with placebo, and 40% of those who received aspirin achieved a relative reduction in HFF of at least 30% compared with 12.5% of ...

While quite a few studies reported fatal bleeds linked to aspirin use, especially in older patients, one interpretation of the results also suggests that aspirin’s anti-platelet action is ...

Therefore, PAC and aspirin may represent a possible therapeutic approach for patients hospitalized with COVID‐19. A careful evaluation of thromboembolic and bleeding risk is needed. Due to the high ...